ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,838 | +965.3% | 12,630 | +1262.5% | 0.00% | – |
| Q1 2021 | $35,000 | -97.2% | 927 | -94.8% | 0.00% | -100.0% |
| Q4 2020 | $1,246,000 | +80.6% | 17,886 | +22.3% | 0.00% | 0.0% |
| Q3 2020 | $690,000 | -11.3% | 14,625 | -8.5% | 0.00% | 0.0% |
| Q2 2020 | $778,000 | +2.4% | 15,988 | -73.4% | 0.00% | 0.0% |
| Q1 2020 | $760,000 | +25.0% | 60,003 | +7.3% | 0.00% | – |
| Q4 2019 | $608,000 | – | 55,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |